Affiliation: MedImmune Vaccines
- Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infectionTaff Jones
MedImmune, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
Curr Opin Investig Drugs 11:964-70. 2010..If Vacc-4x vaccinees demonstrate significantly better responses than the placebo group in this trial, the prospects for Vacc-4x could be highly promising...
- IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infectionTaff Jones
MedImmune Inc, 297 N Bernardo Ave, Mountain View, CA 94043, USA
Curr Opin Mol Ther 10:407-17. 2008..Additional phase II trials were ongoing in these groups at the time of publication and phase III trials were planned for 2009...
- IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infectionTaff Jones
Clinical Testing Laboratories, MedImmune, 297 N Bernardo Avenue, Mountain View, CA 94043, USA
Curr Opin Mol Ther 11:90-6. 2009..The results suggests that IC-51 is fully compliant with the stringent regulatory requirements set by the WHO, has an acceptable safety profile and is non-inferior to JE-VAX...
- GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infectionTaff Jones
MedImmune, Clinical Testing Laboratories, Mountain View, CA 94043, USA
Curr Opin Mol Ther 11:337-45. 2009..With the enormous demand for an effective vaccine in the event of an H5N1 pandemic, GSK's inactivated split H5N1 virus vaccine likely will be a highly valued product...
- Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsRaburn M Mallory
MedImmune, LLC, Gaithersburg, Maryland, United States of America
PLoS ONE 5:e13755. 2010..The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults...
- Remune. Immune ResponseDerhsing Lai
Vincogen Corp, Yardley, PA 19067, USA
Curr Opin Investig Drugs 3:391-8. 2002..Analysts at Lehman Brothers predicted in September 2001, that the product would be launched onto the market with sales of US$150 million in 2004...
- A chimeric live attenuated vaccine against Japanese encephalitisTaff Jones
ID Biomedical Corp of Quebec, 7150 Frederick Banting, Montreal H4S 2A1, Quebec, Canada
Expert Rev Vaccines 3:243-8. 2004..It therefore appears to be a cost-effective prophylactic vaccine against this debilitating disease...